Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Cancers|November 27, 2025
Results of the First Folate Receptor Alpha Testing Trial by the German Quality Assurance Initiative in Pathology (QuIP<sup>®</sup>)Alexander Scheiter, Sven Mattern, Verena Gassenmaier, et al.
BMC Cancer|October 31, 2018
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancerPaul Gass, Michael P Lux, Claudia Rauh, et al.
Cancers|October 13, 2021
<i>MET</i> Amplification in Non-Small Cell Lung Cancer (NSCLC)-A Consecutive Evaluation Using Next-Generation Sequencing (NGS) in a Real-World SettingChristoph Schubart, Robert Stöhr, Lars Tögel, et al.
The American Journal of Surgical Pathology|May 17, 2019
Nuclear NR4A3 Immunostaining Is a Specific and Sensitive Novel Marker for Acinic Cell Carcinoma of the Salivary GlandsFlorian Haller, Alena Skálová, Stephan Ihrler, et al.
Scientific Reports|September 26, 2020
HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatmentFranziska M Wuerfel, Hanna Huebner, Lothar Häberle, et al.
Geburtshilfe Und Frauenheilkunde|January 5, 2024
RANK and RANKL Expression in Tumors of Patients with Early Breast CancerAnnika Behrens, Lena Wurmthaler, Felix Heindl, et al.
Cancers|November 13, 2021
Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular SubtypesRamona Erber, Sareetha Kailayangiri, Hanna Huebner, et al.
Breast (Edinburgh, Scotland)|June 22, 2021
Mammographic density and prognosis in primary breast cancer patientsFelix Heindl, Peter A Fasching, Alexander Hein, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2023
Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer - A single-arm phase II trial (NeoImmunoboost, AGO-B-041)Peter A Fasching, Alexander Hein, Hans-Christian Kolberg, et al.
Archives of Gynecology and Obstetrics|June 5, 2024
Correlation of RANK and RANKL with mammographic density in primary breast cancer patientsMarius Wunderle, Felix Heindl, Annika S Behrens, et al.
Pageof 10